Friday, July 20, 2007

ImaRx Therapeutics sees IPO price to be lower at $5/shr

(Reuters) - The Tucson, Arizona-based company told the U.S. Securities
and Exchange Commission that Maxim Group LLC and I-Bankers
Securities Inc. were underwriting the IPO.




The company has applied for a Nasdaq listing under the
symbol "IMRX."



Read more at Reuters.com Government Filings News

No comments: